Investing.com – U.S. stocks were mixed after the close on Tuesday, as gains in the Telecoms, Basic Materials and Oil & Gas sectors led shares higher while losses in the Consumer...
Investing.com - Stocks struggled for most of the day until a late round of buying offset rising interest rates and weakness in big tech stocks. The S&P 500 turned a small loss...
Manufacturing issues plague the start-up.
ACADIA Pharmaceuticals ACAD made a monster move on Monday on good news and then pulled back. On Tuesday, it was up 2.37, or 6%, to 41.22, on 7.4 million shares. I think...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Strong Sell||Sell||Strong Sell||Strong Sell|
|Technical Indicators||Neutral||BUY||Strong Sell||Strong Buy||Strong Sell|
|Summary||Sell||Neutral||Strong Sell||Strong Sell||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Belt Hold Bearish||15||Current|
|Doji Star Bearish||1W||1||Sep 15, 2019|
|Three Outside Down||5H||1||Sep 23, 2019 08:00AM|
|Engulfing Bearish||5H||2||Sep 20, 2019 03:00PM|
|Bank of America||29.52||29.62||29.17||-0.07||-0.24%||52.24M||23/09|
Nektar Therapeutics is a biopharmaceutical company that discovers and develops medicines in areas of high unmet medical need. The Company's research and development pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain. It leverages its chemistry platform to discover and design new drug candidates. These drug candidates utilize its polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action. Its programs include Immuno-oncology (I-O), Immunology, Pain-NKTR-181 and Oncology-ONZEALD. It is developing medicines designed to directly or indirectly modulate the activity of key immune cells, such as cytotoxic T cells and Natural Killer (NK) cells, to increase their numbers and improve their function to recognize and attack cancer cells.Read More
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.